2 retirement shares that long-term investors should consider for steady income
Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records of solid dividend payouts.
Hosted on MSN14h
Study Finds Exenatide Not Beneficial for Parkinson Disease
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...
The drug industry is having its own DeepSeek moment
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
Why Britain failed to close £450m AstraZeneca deal
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...